NanoViricides, Inc. (NNVC)
1.09
+0.01
(+0.93%)
USD |
NYAM |
Sep 09, 13:58
NanoViricides Debt to Equity Ratio : 0.00 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.0011 |
| June 30, 2022 | 0.0041 |
| March 31, 2022 | 0.0067 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0008 |
| June 30, 2021 | 0.0032 |
| March 31, 2021 | 0.0052 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.0369 |
| June 30, 2020 | 0.0526 |
| March 31, 2020 | 0.0825 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.1376 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.2265 |
| June 30, 2017 | 0.1947 |
| March 31, 2017 | 0.1666 |
| December 31, 2016 | 0.4928 |
| September 30, 2016 | 0.4456 |
| June 30, 2016 | 0.3735 |
| March 31, 2016 | 0.3431 |
| December 31, 2015 | 0.2771 |
| September 30, 2015 | 0.2552 |
| June 30, 2015 | 0.3608 |
| March 31, 2015 | 0.2701 |
| December 31, 2014 | 0.3622 |
| September 30, 2014 | 0.2078 |
| June 30, 2014 | 0.8547 |
| March 31, 2014 | 0.1214 |
| December 31, 2013 | 0.3667 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.22M |
| Total Liabilities (Quarterly) | 1.065M |
| Shareholders Equity (Quarterly) | 9.154M |
| Current Ratio | 3.170 |